16 Stocks Moving In Friday's Pre-Market Session

Gainers

• Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) rose 13.6 percent to $3.00 in pre-market trading as the company disclosed that voclosporin achieved primary and all pre-specific secondary endpoints in Phase IIb AURA-LV study for LN.
• Lexmark International Inc (NYSE: LXK) shares rose 13.4 percent to $39.85 in pre-market trading after the company disclosed that it has received clearance from the Committee on Foreign Investment in the United States to proceed with proposed buyout.
• Repros Therapeutics Inc (NASDAQ: RPRX) rose 11.4 percent to $2.35 in pre-market trading after gaining 0.96 percent on Thursday.
• Devon Energy Corp (NYSE: DVN) shares rose 5.8 percent to $45.55 in pre-market trading after gaining 3.51 percent on Thursday.
• Cempra Inc (NASDAQ: CEMP) rose 4.3 percent to $24.90 in the pre-market trading after the company reported interim results from Phase 2 study of solithromycin.
• Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) rose 4.1 percent to $7.60 in pre-market trading after gaining 3.69 percent on Thursday.
• Catabasis Pharmaceuticals Inc (NASDAQ: CATB) rose 3.8 percent to $6.49 in pre-market trading after surging 39.51 percent on Thursday. James Flynn disclosed a 4.21 percent passive stake in Catabasis Pharmaceuticals.
• NXP Semiconductors NV (NASDAQ: NXPI) shares rose 3 percent to $98.99 in pre-market trading. QUALCOMM, is said in talks to acquire NXP Semiconductors, according to sources as reported by Dow Jones on Thursday.
• QUALCOMM, Inc. (NASDAQ: QCOM) rose 2 percent to $68.81 in pre-market trading. QUALCOMM, is said in talks to acquire NXP Semiconductors, according to sources as reported by Dow Jones on Thursday. The sources said a deal, which could happen over the next two to three months, would likely be valued at over $30 billion, though NXP's market cap was already over $32 billion following the report. Mizuho Securities upgraded Qualcomm from Neutral to Buy.
• Costco Wholesale Corporation (NASDAQ: COST) rose 2 percent to $150.51 in pre-market trading as the company reported stronger-than-expected earnings for its fourth quarter on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) shares fell around 62.7 percent to $0.44 in pre-market trading after the company disclosed interim results from its Tarloxotinib program. The company announced that it will discontinue investment in its Tarloxotinib program and will focus on evofosfamide program and earlier-stage opportunities.
• CalAmp Corp. (NASDAQ: CAMP) shares fell 14.5 percent to $14.03 in pre-market trading. CalAmp reported in-line earnings for the second quarter, but sales missed expectations. The company also issued disappointing guidance for the third quarter.
• Delcath Systems, Inc. (NASDAQ: DCTH) shares fell 13 percent to $3.00 in pre-market trading after the company reported proposed offering of common stock and warrants.
• Ophthotech Corp (NASDAQ: OPHT) fell 10.4 percent to $48.50 in pre-market trading after dropping 5.55 percent on Thursday.
• BGC Partners, Inc. (NASDAQ: BGCP) shares fell 5.6 percent to $8.30 in pre-market trading after the company lowered its Q3 revenue forecast.
• Extended Stay America Inc (NYSE: STAY) shares fell 3.4 percent to $14.03 in pre-market trading after the company reported the pricing of secondary offering and repurchase of Paired Shares.